World Journal of Dentistry

Register      Login

VOLUME 2 , ISSUE 1 ( January-March, 2011 ) > List of Articles


T-Cell-Rich Diffuse Large B-cell Lymphoma Presenting as an Intraosseous Maxillary Neoplasm

Gururaj Patil Bheemanagouda, Kaveri Satish Hallikeri, Rekha Pillai Krishna

Citation Information : Bheemanagouda GP, Hallikeri KS, Krishna RP. T-Cell-Rich Diffuse Large B-cell Lymphoma Presenting as an Intraosseous Maxillary Neoplasm. World J Dent 2011; 2 (1):53-55.

DOI: 10.5005/jp-journals-10015-1054

Published Online: 01-03-2011

Copyright Statement:  Copyright © 2011; The Author(s).


Non-Hodgkin lymphomas are a group of highly diverse malignancies with great tendency to affect organs and tissues that do not ordinarily contain lymphoid cells. T-cell/histiocyte-rich large B-cell lymphoma (TCRBCL) is an uncommon histological variant of large B-cell non- Hodgkin lymphoma, morphologically characterized by a minor population of clonal B-cells distributed in a background of prominent reactive T lymphocytes. This is an interesting case of extranodal isolated TCRBCL in jaw bone and to our knowledge this is the first report of its kind in a nonimmune compromised 40-year-old female. An increase in the number of case reports of non-Hodgkin lymphoma in head and neck region definitely makes it to be included as differential diagnosis. The patient has completed 5 years of therapy with no evidence of recurrence.

PDF Share
  1. On behalf of the Houston MALT lymphoma workshop. Interobserver variation in the histopathological assessment of malt/malt lymphoma: Towards a consences. Blood Cells Mol Dis 2005;34:6-16.
  2. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's lymphoma classification project. J Clin Oncol 1998;16:2780-95.
  3. In diffuse large B-cell lymphoma. Jaffe ES, Harris NL, Stein H (Eds). Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press 2001;171-74.
  4. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol 1994;18:455-65.
  5. Primary T-cellrich B-cell lymphoma of the ethmoid sinus: A case report with 5 years of follow-up. Arch Pathol Lab Med Aug 2000;124(8):1213-16.
  6. T-cell-rich large B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas. Am J Pathol Dec 1998;153(6):1707-15.
  7. T-cell-rich B-cell lymphoma: A clinicopathologic study of eight cases. Am J Clin Pathol 1995;103:65-75.
  8. T-cell-rich large B-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol 1996;20:193-201.
  9. Nodular lymphocyte-predominant Hodgkin's lymphoma or T-cell/Histiocyte-rich large B-cell lymphoma: The problem in “Grey Zone” lymphomas. Int J Clin Exp Pathol 2008;1:300-05.
  10. T-cell/histiocyte-rich large B-cell lymphoma: A distinct clinicopathologic entity. J Clin Oncol 2002;20:1269-77.
  11. T-cell-rich B-cell lymphomas: Diagnosis and response to therapy of 44 patients. J Clin Oncol 1995;13:1742-50.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.